scorecardresearch
Wednesday, August 13, 2025
TopicUSFDA

Topic: USFDA

USFDA approves first at-home test kit for detecting Covid

While some Covid tests allow people to to mail in samples collected at home, this is the first that can be fully self-administered & provides results at home in 30 minutes or less.

Eli Lilly’s Covid antibody drug gets emergency-use clearance by USFDA

The clearance gives doctors an option for tackling the coronavirus in high-risk patients before they’re sick enough to require hospitalization.

‘Deep state’ FDA is taking a beating as review of Covid vaccine approaches

At a time when the FDA needs the public’s trust more than ever, the US agency has been dragged into the political fray in a series of compounding incidents.

FDA wasn’t wrong in allowing plasma therapy for Covid patients in US

FDA's decision set off a media firestorm, with politicians, public-health officials & medical professionals insisting that the Trump administration was playing politics with science.

US FDA rows back on plasma therapy, says it doesn’t give dramatic benefit to Covid patients

FDA Commissioner Stephen Hahn had said Sunday that blood plasma from Covid-19 survivors given to new patients could save huge numbers of lives.

US FDA expands use of plasma therapy to treat Covid patients

The move will make it easier to receive the treatment, which Trump has promoted even though studies to prove its benefits haven’t been completed.

Pakistan has 1 lakh cases post lockdown, Sweden’s failed pandemic model & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

US drug regulator approves use of diabetes drug, also sold in India, to prevent heart attack

The drug Farxiga is sold in India by UK-based pharma giant AstraZeneca under the brand name ‘Forxiga’ to treat type 2 diabetes.

US FDA says smokers could have higher risk of catching coronavirus

FDA had earlier said smokers may have worse outcomes from Covid-19, but hadn’t been explicit about whether that included chances of infection in the first place.

How the humble hydroxychloroquine has become India’s unlikely new global strategic asset

Donald Trump has labelled hydroxychloroquine a 'game-changer' in the fight against Covid-19. Indian pharma companies have gained significantly from this.

On Camera

Musk’s golden touch is on the line. Tesla needs him to do what he does best — sell a pen

Tesla sales have been sliding, profits have been shrinking, and brand loyalty is faltering. Elon Musk’s politics has something to do with it.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

India expands Southeast Asia defence footprint with new joint venture in Philippines

Memorandum of understanding between SMPP and ADFC was signed during state visit of Philippines’ President to India earlier this month.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.